Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.

Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.

<h4>Introduction</h4>End-stage renal disease (ESRD) strongly associates with cardiovascular disease (CVD) risk. This risk is not completely mitigated by renal replacement therapy. Endothelial dysfunction (ED) and low-grade inflammation (LGI) may contribute to the increased CVD risk. Howe...

Full description

Bibliographic Details
Main Authors: April C E van Gennip, Natascha J H Broers, Karlien J Ter Meulen, Bernard Canaud, Maarten H L Christiaans, Tom Cornelis, Mariëlle A C J Gelens, Marc M H Hermans, Constantijn J A M Konings, Jeroen B van der Net, Frank M van der Sande, Casper G Schalkwijk, Frank Stifft, Joris J J M Wirtz, Jeroen P Kooman, Remy J H Martens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0222547

Internet

https://doi.org/10.1371/journal.pone.0222547

Similar Items